In last trading session, Citius Pharmaceuticals Inc (NASDAQ:CTXR) saw 1.56 million shares changing hands with its beta currently measuring 1.11. Company’s recent per share price level of $2.15 trading at -$0.32 or -12.96% at ring of the bell on the day assigns it a market valuation of $18.48M. That closing price of CTXR’s stock is at a discount of -1144.19% from its 52-week high price of $26.75 and is indicating a discount of -12.56% from its 52-week low price of $2.42.
For Citius Pharmaceuticals Inc (CTXR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 1.3 in the current quarter.
Citius Pharmaceuticals Inc (NASDAQ:CTXR) trade information
Upright in the red during last session for losing -12.96%, in the last five days CTXR remained trading in the red while hitting it’s week-highest on Wednesday, 02/19/25 when the stock touched $2.15 price level, adding 27.61% to its value on the day. Citius Pharmaceuticals Inc’s shares saw a change of -46.25% in year-to-date performance and have moved -18.25% in past 5-day. Citius Pharmaceuticals Inc (NASDAQ:CTXR) showed a performance of -34.85% in past 30-days.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.78M for the same. And 3 analysts are in estimates of company making revenue of 3.95M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 20.90% during past 5 years.
Citius Pharmaceuticals Inc (NASDAQ:CTXR)’s Major holders
ARMISTICE CAPITAL, LLC is the top institutional holder at CTXR for having 10.16 million shares of worth $5.93 million. And as of 2024-06-30, it was holding 6.3845 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 6.33 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.9776 of outstanding shares, having a total worth of $3.69 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 165.58 shares of worth $0.36 million or 1.93% of the total outstanding shares. The later fund manager was in possession of 78.32 shares on Sep 30, 2024 , making its stake of worth around $0.17 million in the company or a holder of 0.91% of company’s stock.
